Cargando…

Identification of long non-coding RNAs in advanced prostate cancer associated with androgen receptor splicing factors

The molecular and cellular mechanisms of development of castration-resistant prostate cancer (CRPC) remain elusive. Here, we analyzed the comprehensive and unbiased expression profiles of both protein-coding and long non-coding RNAs (lncRNAs) using RNA-sequencing to reveal the clinically relevant mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayama, Ken-ichi, Fujimura, Tetsuya, Suzuki, Yutaka, Inoue, Satoshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378231/ https://www.ncbi.nlm.nih.gov/pubmed/32704143 http://dx.doi.org/10.1038/s42003-020-01120-y

Ejemplares similares

Long non‐coding RNAs and prostate cancer
por: Misawa, Aya, et al.
Publicado: (2017)

Androgen‐induced lncRNA POTEF‐AS1 regulates apoptosis‐related pathway to facilitate cell survival in prostate cancer cells
por: Misawa, Aya, et al.
Publicado: (2017)

Estrogen and Androgen Blockade for Advanced Prostate Cancer in the Era of Precision Medicine
por: Fujimura, Tetsuya, et al.
Publicado: (2018)

Significance of microRNAs in Androgen Signaling and Prostate Cancer Progression
por: Takayama, Ken-ichi, et al.
Publicado: (2017)

Androgen‐responsive tripartite motif 36 enhances tumor‐suppressive effect by regulating apoptosis‐related pathway in prostate cancer
por: Kimura, Naoki, et al.
Publicado: (2018)

RUNX1, an androgen- and EZH2-regulated gene, has differential roles in AR-dependent and -independent prostate cancer
por: Takayama, Ken-ichi, et al.
Publicado: (2014)

Splicing Factors Have an Essential Role in Prostate Cancer Progression and Androgen Receptor Signaling
por: Takayama, Ken-ichi
Publicado: (2019)

Subtype-specific collaborative transcription factor networks are promoted by OCT4 in the progression of prostate cancer
por: Takayama, Ken-ichi, et al.
Publicado: (2021)

Identification of DNA damage response-related genes as biomarkers for castration-resistant prostate cancer
por: Oshima, Masashi, et al.
Publicado: (2023)

CLDN8, an androgen‐regulated gene, promotes prostate cancer cell proliferation and migration
por: Ashikari, Daisaku, et al.
Publicado: (2017)

Ribonuclease H2 Subunit A Preserves Genomic Integrity and Promotes Prostate Cancer Progression
por: Kimura, Naoki, et al.
Publicado: (2022)

Androgen Receptor-Related Non-coding RNAs in Prostate Cancer
por: Yang, Yongyong, et al.
Publicado: (2021)

Long Non-coding RNAs Involved in Metabolic Alterations in Breast and Prostate Cancers
por: Kamada, Shuhei, et al.
Publicado: (2020)

Rare Splice Variants in Long Non-Coding RNAs
por: Sen, Rituparno, et al.
Publicado: (2017)

Splice Variants of Androgen Receptor and Prostate Cancer
por: Caffo, Orazio, et al.
Publicado: (2016)

Crosstalk of the Androgen Receptor with Transcriptional Collaborators: Potential Therapeutic Targets for Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2017)

Interaction between Non-Coding RNAs and Androgen Receptor with an Especial Focus on Prostate Cancer
por: Taheri, Mohammad, et al.
Publicado: (2021)

Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2015)

Recent Discoveries in the Androgen Receptor Pathway in Castration-Resistant Prostate Cancer
por: Obinata, Daisuke, et al.
Publicado: (2020)

Identification of new octamer transcription factor 1‐target genes upregulated in castration‐resistant prostate cancer
por: Yamamoto, Shinichiro, et al.
Publicado: (2019)

Androgen responsive intronic non-coding RNAs
por: Louro, Rodrigo, et al.
Publicado: (2007)

Ratio of the expression levels of androgen receptor splice variant 7 to androgen receptor in castration refractory prostate cancer
por: Sekine, Yoshitaka, et al.
Publicado: (2021)

Long-term results of radical prostatectomy with immediate adjuvant androgen deprivation therapy for pT3N0 prostate cancer
por: Sato, Yuzuri Tsurumaki, et al.
Publicado: (2014)

OCT1-target neural gene PFN2 promotes tumor growth in androgen receptor-negative prostate cancer
por: Obinata, Daisuke, et al.
Publicado: (2022)

TRIM44 promotes cell proliferation and migration by inhibiting FRK in renal cell carcinoma
por: Yamada, Yuta, et al.
Publicado: (2020)

Correction: Identification of Androgen Receptor Splice Variants in the Pten Deficient Murine Prostate Cancer Model
por: Liang, Mengmeng, et al.
Publicado: (2016)

Mechanisms of Apoptosis-Related Long Non-coding RNAs in Ovarian Cancer
por: Takeiwa, Toshihiko, et al.
Publicado: (2021)

Identification of androgen-responsive lncRNAs as diagnostic and prognostic markers for prostate cancer
por: Wan, Xuechao, et al.
Publicado: (2016)

Role of androgen receptor splice variants in prostate cancer metastasis
por: Xu, Jin, et al.
Publicado: (2016)

Cold-Dependent Expression and Alternative Splicing of Arabidopsis Long Non-coding RNAs
por: Calixto, Cristiane P. G., et al.
Publicado: (2019)

Long non-coding RNAs are involved in alternative splicing and promote cancer progression
por: Ouyang, Jiawei, et al.
Publicado: (2021)

Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
por: Shih, Jing-Wen, et al.
Publicado: (2015)

Long non-coding RNAs: new frontiers for advancing personalized cancer medicine in prostate cancer
por: Ghiam, Alireza Fotouhi, et al.
Publicado: (2017)

Androgen receptor splice variants and prostate cancer: From bench to bedside
por: Wadosky, Kristine M., et al.
Publicado: (2017)

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate Cancer
por: Smolle, Maria A., et al.
Publicado: (2017)

Carcinogenesis in prostate cancer: The role of long non-coding RNAs
por: Aird, John, et al.
Publicado: (2018)

Pyrrole-imidazole polyamide targeted to break fusion sites in TMPRSS2 and ERG gene fusion represses prostate tumor growth
por: Obinata, Daisuke, et al.
Publicado: (2014)

Toremifene, a selective estrogen receptor modulator, significantly improved biochemical recurrence in bone metastatic prostate cancer: a randomized controlled phase II a trial
por: Fujimura, Tetsuya, et al.
Publicado: (2015)

MicroRNAs Are Mediators of Androgen Action in Prostate and Muscle
por: Narayanan, Ramesh, et al.
Publicado: (2010)

The Advancement of Long Non-Coding RNAs in Cholangiocarcinoma Development
por: Jiang, Fengru, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t99a6nfq3qrt103ernaq43itv1